Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC.

 (AGN)

14
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Allergan, Inc. : Allergan Announces Quarterly Conference Call

07/06/2012| 05:35pm US/Eastern
Recommend:
0

Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the Company's second quarter 2012 results on Wednesday, August 1, 2012. The live Webcast can be accessed through the Allergan Web site, www.allergan.com, beginning at 8:00 a.m. Pacific Time. A replay of the discussion will be available shortly after the call and can be accessed through www.allergan.com, or by dialing 1-800-518-0083 for domestic locations or 1-402-220-9088 for international locations. A passcode will not be required. The replay will be available for one week following the live call.

It is Allergan's policy to comply fully with Regulation FD. Therefore, Allergan intends to utilize this Webcast event to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. Allergan does not plan to report or comment on its progress during the current fiscal quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to Allergan. During a quarter, Allergan's commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. Allergan will make no comments with respect to market rumors or speculation.

Allergan, Inc.
Jim Hindman
Joann Bradley
David Nakasone
(714) 246-4636


© Business Wire 2012
Recommend :
0
Partner Area
React to this article
 
Latest news on ALLERGAN, INC.
4d ago ALLERGAN, INC.: ex-dividend day
05/02 ALLERGAN, INC.: New Guidelines Recommend Medical and Surgical Therapies Added t..
05/02 ALLERGAN, INC.: FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA? ..
05/01DJAllergan Reports Drug Development Delay, Lower Profits
05/01DJAllergan Reports Drug Development Delay, Lower Profits
05/01DJALLERGAN, INC.: Allergan 1st-Quarter Profit Slumps Amid Expected Loss on Sale o..
05/01 ALLERGAN, INC.: Allergan Reports First Quarter 2013 Operating Results
04/30 ALLERGAN, INC.: Allergan Announces Death of Stephen J. Ryan, M.D.
04/26DJALLERGAN, INC.: FDA Warns of Counterfeit Botox
04/16DJALLERGAN, INC.: FDA Doesn't Approve Allergan's Levadex for Migraines
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.